Listar MEDICINA por autor "García Pavía, Pablo"
Mostrando ítems 41-60 de 70
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Olivotto, Iacopo; Oreziak, Artur; Barriales Villa, Roberto; Abraham, Theodore P.; Masri, Ahmad; García Pavía, Pablo; Jacoby, Daniel (The Lancet, 2020)
-
Murine models of ARVC: what have we learned and where do we go? Insight for therapeutics. Padrón Barthe, Laura; Domínguez, Fernando; García Pavía, Pablo; Lara Pezzi, Enrique (Basic Research in Cardiology, 2017)
-
Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy. Salazar-Mendiguchía, Joel; Pablo Ochoa, Juan; Palomino-Doza, Julián; Domínguez, Fernando; Díez-López, Carles; Akhtar, Mohammed; Ramiro-León, Soraya; Clemente, María M.; Pérez-Cejas, Antonia; Robledo, María; Gómez-Díaz, Iria; Peña-Peña, María Luisa; Peña-Peña, María Luisa; Climent, Vicente; Salmerón-Martínez, Francisco; Hernández, Celestino; García-Granja, Pablo E.; Mogollón, M. Victoria; Cárdenas-Reyes, Ivonne; Cicerchia, Marcos; García-Giustiniani, Diego; Lamounier, Arsonval Jr.; Gil-Fournier, Belén; Díaz-Flores, Felícitas; Salguero, Rafael; Santomé, Luis; Syrris, Petros; Olivé, Montse; García Pavía, Pablo; Ortiz-Genga, Martín; Elliott, Perry M.; Monserrat, Lorenzo (Heart, 2020)
-
Natural History of MYH7-Related Dilated Cardiomyopathy. De Frutos, Fernando; Ochoa, Juan Pablo; García Pavía, Pablo (Journal of the American College of Cardiology, 2022)
-
Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker. López-Sainz, Ángela; Climent, Vicente; Ripoll-Vera, Tomas; Espinosa, Maria Angeles; Barriales-Villa, Roberto; Navarro, Marina; Limeres, Javier; Domingo, Diana; Kasper, David C.; García Pavía, Pablo (Orphanet Journal of Rare Diseases, 2019)
-
Perfil clínico y evolución de la amiloidosis cardiaca en un centro español de referencia. López Sainz, Ángela; Hernández-Hernández, Aitor; González López, Esther; Domínguez, Fernando; Restrepo-Cordoba, María Alejandra; Cobo Marcos, Marta; Gómez Bueno, Manuel; Hernández Pérez, Francisco José; Oteo, Juan Francisco; García Pavía, Pablo (Revista Española de Cardiología, 2021)
-
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid. García Pavía, Pablo; Aus dem Siepen, Fabian; Donal, Erwan; Damy, Thibaud (New England Journal of Medicine, 2023)
-
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences. Verdonschot, Job A.J.; Merlo, Marco; Domínguez, Fernando; Wang, Ping; Henkens, Michiel T.H.M.; Adriaens, Michiel E.; Hazebroek, Mark R.; Mase, Marco; Escobar, Luis E.; Cobas-Paz, Rafael; Derks, Kasper W.J.; Van den Wijngaard, Arthur; Krapels, Ingrid P.C.; Brunner, Han G.; Sinagra, Gianfranco; García Pavía, Pablo; Heymans, Stephane R.B. (European Heart Journal, 2020)
-
POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas. Calvete, Oriol; García Pavía, Pablo; Domínguez, Fernando; Mosteiro, Lluc; Pérez-Cabornero, Lucía; Cantalapiedra, Diego; Zorio, Esther; Ramón y Cajal, Teresa; Crespo‐Leiro, Maria G.; Teulé, Álex; Lázaro, Conxi; Morente, Manuel M.; Urioste, Miguel; Benitez, Javier (Journal of the American Heart Association, 2019)
-
Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy. García Pavía, Pablo (European Journal of Heart Failure, 2021)
-
Prognostic factors of Infective Endocarditis in Patients on Hemodialysis: A Case Series from a National Multicenter Registry. Ramos, Antonio; Roque Rojas, Fernando; Fariñas Álvarez, Mª Carmen; Muñoz García, Patricia; Verde Moreno, Eduardo; Cuerpo Caballero, Gregorio Pablo; Alarcón González, Arístides; Lepe Jiménez, José Antonio; Miró Meda, José María; Plata Ciézar, Antonio; Goenaga Sánchez, Miguel Ángel; García Rosado, Dácil; Martínez Monzonis, Amparo; De la Torre Lima, Javier; García Pavía, Pablo (International Journal of Cardiology, 2017)
-
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy. Suay Corredera, Carmen; García Pavía, Pablo; Alegre Cebollada, Jorge (Journal of Biological Chemistry, 2021)
-
Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β. Padrón-Barthe, Laura; Villalba-Orero, María; Gómez-Salinero, Jesús M.; Domínguez, Fernando; Román, Marta; Larrasa-Alonso, Javier; Ortiz-Sánchez, Paula; Martínez, Fernando; López-Olañeta, Marina; Bonzón-Kulichenko, Elena; Vázquez, Jesús; Martí-Gómez, Carlos; Santiago, Demetrio J.; Prados, Belén; Giovinazzo, Giovanna; Gómez-Gaviro, María Victoria; Priori, Silvia; García Pavía, Pablo; Lara-Pezzi, Enrique (Circulation, 2019)